NYSEARCA:KEMX

KraneShares MSCI Emerging Markets ex China Index ETF Stock Forecast, Price & News

$31.49
+0.25 (+0.80 %)
(As of 09/21/2021 12:00 AM ET)
Add
Today's Range
$31.35
$31.57
50-Day Range
$30.92
$33.10
52-Week Range
$23.20
$33.24
Volume1,805 shs
Average Volume7,825 shs
Market Capitalization$25.19 million
P/E RatioN/A
Dividend Yield1.56%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive KEMX News and Ratings via Email

Sign-up to receive the latest news and ratings for KraneShares MSCI Emerging Markets ex China Index ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer KraneShares
Fund NameKraneShares MSCI Emerging Markets ex China Index ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:KEMX
Inception Date4/12/2019
Fund ManagerMark Schlarbaum, Jonathan Shelon
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMSCI Emerging Markets ex China Index
CategoryBroad Equity
FocusBroad Equity
Development LevelEmerging Markets
RegionEmerging Markets

Fund Statistics

Assets Under Management$25.55 million
Average Daily Volume$2,743.00
Discount/Premium-0.67%

ETF Expenses

Management Fee0.58%
Other Expenses0.01%
Total Expenses0.59%
Fee Waiver-0.10%
Net Expenses0.49%

Administrator, Advisor and Custodian

AdministratorSEI Investments Global Funds Services
AdvisorKrane Funds Advisors, LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market Maker

Geographic Exposure of KEMX

Currency Exposure of KEMX

Sector Exposure of KEMX

Industry Exposure of KEMX

speech bubbles
speech bubbles











KraneShares MSCI Emerging Markets ex China Index ETF (NYSEARCA:KEMX) Frequently Asked Questions

What stocks does MarketBeat like better than KraneShares MSCI Emerging Markets ex China Index ETF?

Wall Street analysts have given KraneShares MSCI Emerging Markets ex China Index ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but KraneShares MSCI Emerging Markets ex China Index ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has KraneShares MSCI Emerging Markets ex China Index ETF's stock price been impacted by Coronavirus (COVID-19)?

KraneShares MSCI Emerging Markets ex China Index ETF's stock was trading at $22.2387 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KEMX shares have increased by 41.6% and is now trading at $31.4874.
View which stocks have been most impacted by COVID-19
.

Is KraneShares MSCI Emerging Markets ex China Index ETF a good dividend stock?

KraneShares MSCI Emerging Markets ex China Index ETF pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.56%.
View KraneShares MSCI Emerging Markets ex China Index ETF's dividend history.

What is KraneShares MSCI Emerging Markets ex China Index ETF's stock symbol?

KraneShares MSCI Emerging Markets ex China Index ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "KEMX."

Who are KraneShares MSCI Emerging Markets ex China Index ETF's major shareholders?

KraneShares MSCI Emerging Markets ex China Index ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include 3D L Capital Management LLC (58.08%), Envestnet Asset Management Inc. (8.94%), Citadel Advisors LLC (1.85%), Flow Traders U.S. LLC (0.82%) and Patriot Financial Group Insurance Agency LLC (0.26%).

Which institutional investors are selling KraneShares MSCI Emerging Markets ex China Index ETF stock?

KEMX stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, and Envestnet Asset Management Inc..

Which institutional investors are buying KraneShares MSCI Emerging Markets ex China Index ETF stock?

KEMX stock was bought by a variety of institutional investors in the last quarter, including 3D L Capital Management LLC, Flow Traders U.S. LLC, and Patriot Financial Group Insurance Agency LLC.

How do I buy shares of KraneShares MSCI Emerging Markets ex China Index ETF?

Shares of KEMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is KraneShares MSCI Emerging Markets ex China Index ETF's stock price today?

One share of KEMX stock can currently be purchased for approximately $31.49.

How much money does KraneShares MSCI Emerging Markets ex China Index ETF make?

KraneShares MSCI Emerging Markets ex China Index ETF has a market capitalization of $25.19 million.


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.